Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2
BCG is the most efficient adjuvant therapy for high-risk, non-muscle-invasive bladder cancer (NMIBC). Both innate and adaptive immune responses have been implicated in BCG-mediated effects. BCG vaccination can boost innate immune responses via trained immunity (TI), resulting in an increased resist...
Main Authors: | Renate Pichler, Gabriel Diem, Hubert Hackl, Jiří Koutník, Laura S. Mertens, David D`Andrea, Benjamin Pradere, Francesco Soria, Andrea Mari, Ekaterina Laukhtina, Wojciech Krajewski, Jeremy Yuen-Chun Teoh, Francesco Del Guidice, Marco Moschini, Martin Thurnher, Wilfried Posch |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1202157/full |
Similar Items
-
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
by: Francesco Del Giudice, et al.
Published: (2022-02-01) -
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer
by: Renate Pichler, et al.
Published: (2024-03-01) -
Pott's disease post intravesical BCG
by: Anika Jain
Published: (2023-01-01) -
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis
by: Francesco Del Giudice, et al.
Published: (2023-03-01) -
BCG Sepsis After Intravesical BCG Instillation: A Case Report
by: Meliha Çağla Sönmezer, et al.
Published: (2019-03-01)